Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001446580-25-000065
Filing Date
2025-08-14
Accepted
2025-08-14 10:29:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13770
2 JOINT FILING AGREEMENT corz_sc13g-ex99.htm EX-99 1809
  Complete submission text file 0001446580-25-000065.txt   17516
Mailing Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004
Business Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004 610-617-2600
SUSQUEHANNA SECURITIES, LLC (Filed by) CIK: 0001446580 (see all company filings)

EIN.: 232754552
Type: SCHEDULE 13G

Mailing Address 838 WALKER ROAD SUITE 21-2105 DOVER DE 19904
Business Address 838 WALKER ROAD SUITE 21-2105 DOVER DE 19904 (425) 998-5300
Core Scientific, Inc./tx (Subject) CIK: 0001839341 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92274 | Film No.: 251215308
SIC: 6199 Finance Services
(CF Office: 09 Crypto Assets)